If Symptoms Return at Month Six New or worsening digestive symptoms long after you reach a stable dose are not typical, and they should not be shrugged off as just the Zepbound. Postmarketing reports for tirzepatide include ileus, intestinal obstruction, and severe constipation with fecal impaction
Experts say one problem is that temporary use could undermine health by diminishing lean muscle mass, every time a person resumes GLP-1s
In May 2023, the FDA warned it had received adverse event reports after patients used compounded semaglutide, a copycat treatment from compounding pharmacies
S.FlierJ
In reality, the roundabout money trail keeps patients in the dark about the true cost of coveragea disconnect that relieves incentives for insurers to negotiate better deals with providers
Microbiol Spectrum 12:e327923 Gray KJ, Gibbs JE (2022) Adaptive immunity, chronic inflammation and the clock